slug: chemotherapy-protocols-feline
nameEn: Chemotherapy Protocols Feline
nameZh: 貓化學治療方案
bodySystem: oncology
description: 貓腫瘤化學治療方案概述，涵蓋貓特有的藥物敏感性、劑量限制及常見腫瘤的化療策略。貓對部分化療藥物的耐受性與犬不同，需特別注意腎毒性。

aliases:
  - { alias: 貓化療方案, language: zh }
  - { alias: 貓腫瘤化療, language: zh }
  - { alias: Feline Chemotherapy, language: en }
  - { alias: Feline Cancer Chemotherapy Protocols, language: en }

species:
  - speciesCommon: cat
    speciesScientific: Felis catus
    prevalence: common
    notes: 貓化療需特別注意物種差異。Cisplatin 對貓禁忌（致死性肺水腫）。Doxorubicin 對貓腎毒性較犬高。5-FU 對貓禁忌（致死性神經毒性）。劑量計算以體重（非BSA）為基礎。

etiology:
  categories:
    - name: 貓禁忌化療藥物
      examples:
        - "Cisplatin：貓禁忌（致死性肺水腫）"
        - "5-Fluorouracil (5-FU)：貓禁忌（致死性神經毒性）"
        - 以上兩藥在任何情況下均不可用於貓
    - name: 貓常用化療方案
      examples:
        - "COP：Cyclophosphamide + Vincristine + Prednisolone（淋巴瘤）"
        - "CHOP 修正方案：使用 Doxorubicin 需監測腎功能"
        - "Lomustine (CCNU)：淋巴瘤、肥大細胞瘤"
        - "Chlorambucil + Prednisolone：低度淋巴瘤、小細胞淋巴瘤"
        - "Carboplatin：注射部位肉瘤、多種實質腫瘤"
        - "Metronomic Chlorambucil：慢性維持治療"

clinicalSigns:
  early:
    - 暫時性食慾下降
    - 嗜睡（化療後 1-3 天）
    - 輕度噁心
  progressive:
    - 嘔吐、腹瀉
    - 骨髓抑制（嗜中性球低下）
    - 腎功能惡化（Doxorubicin 腎毒性）
    - 體重減輕
    - 鬚鬚脫落（常見但無臨床意義）

diagnosis:
  primaryTests:
    - name: 化療前評估
      notes: "CBC、完整生化（特別注意 BUN、Creatinine）、尿液分析。FeLV/FIV 檢測。心臟超音波（Doxorubicin 前）"
    - name: 化療中監測
      notes: "每次化療前 CBC 及腎功能。Doxorubicin 使用期間密切監測腎功能。嗜中性球 >1,500/μL 方可進行"
  differentialDiagnoses:
    - 手術治療
    - 放射治療
    - 免疫治療
    - 姑息治療

treatment:
  medical:
    - "Doxorubicin 貓劑量：1 mg/kg IV（非以 BSA 計算），每 3 週一次"
    - "Doxorubicin 貓累積劑量上限：約 5-6 次（腎毒性限制）"
    - "Carboplatin 200-240 mg/m² IV 每 3-4 週"
    - "Chlorambucil 2 mg PO 每 48-72 小時（慢性淋巴瘤）"
    - "Lomustine 50-60 mg/m² PO 每 4-6 週"
    - 止吐預防（Maropitant）
    - 食慾刺激劑（Mirtazapine 1.88 mg 經皮每 48 小時）

prognosis:
  general: "貓淋巴瘤（高分級）CHOP 方案中位生存時間約 6-9 個月。小細胞淋巴瘤以 Chlorambucil + Prednisolone 治療中位生存時間可達 2-3 年。注射部位肉瘤術後化療可延長無疾病間期。"

prevention:
  - 嚴格遵守貓禁忌藥物清單
  - 密切監測腎功能
  - 化療排泄物安全處理


guidelineRefs:
  - sourceOrg: "Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)"
    title: "2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544803/
    type: consensus
    pmid: "35881647"
  - sourceOrg: Pathogens (Basel, Switzerland)
    title: "Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018-2024)."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12298711/
    type: review
    pmid: "40732763"
  - sourceOrg: Journal of feline medicine and surgery
    title: "Hypoadrenocorticism in cats: a 40-year update."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11437538/
    type: review
    pmid: "39325772"
  - sourceOrg: The Canadian veterinary journal = La revue veterinaire canadienne
    title: "Anesthesia update - Incorporating methadone into companion animal anesthesia and analgesic protocols: A narrative review."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581351/
    type: review
    pmid: "37915778"
  - sourceOrg: The Canadian veterinary journal = La revue veterinaire canadienne
    title: "In-hospital medical management of feline urethral obstruction: A review of recent clinical research."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236633/
    type: review
    pmid: "32675811"